AVTX
NASDAQ · Biotechnology
Avalo Therapeutics Inc
$18.48
-0.81 (-4.20%)
Open$19.45
Previous Close$19.29
Day High$20.10
Day Low$18.29
52W High$24.27
52W Low$4.50
Volume—
Avg Volume1.95M
Market Cap928.83M
P/E Ratio—
EPS$-6.04
SectorBiotechnology
Analyst Ratings
Strong Buy
19 analysts
Price Target
+78.1% upside
Current
$18.48
$18.48
Target
$32.91
$32.91
$27.78
$32.91 avg
$47.11
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 228.1K | 1.54M | 36.29M |
| Net Income | -302,601,754 | -1,835,185,839 | 8.09M |
| Profit Margin | -132,642.4% | -126,010.3% | 22.3% |
| EBITDA | -280,645,620 | -1,796,585,842 | 9.50M |
| Free Cash Flow | — | — | 4.67M |
| Rev Growth | -85.2% | -85.2% | +16.8% |
| Debt/Equity | 0.03 | 0.03 | 0.47 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |